These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 37112902)
1. Comparing Clinical Outcomes of COVID-19 and Influenza-Induced Acute Respiratory Distress Syndrome: A Propensity-Matched Analysis. Virk S; Quazi MA; Nasrullah A; Shah A; Kudron E; Chourasia P; Javed A; Jain P; Gangu K; Cheema T; DiSilvio B; Sheikh AB Viruses; 2023 Apr; 15(4):. PubMed ID: 37112902 [TBL] [Abstract][Full Text] [Related]
2. Differences of respiratory mechanics in mechanical ventilation of acute respiratory distress syndrome between patients with COVID-19 and Influenza A. Chung E; Leem AY; Chung KS; Kang YA; Park MS; Kim YS; Jang HJ; Lee SH Respir Res; 2024 Mar; 25(1):112. PubMed ID: 38448933 [TBL] [Abstract][Full Text] [Related]
3. Risk factor analysis of nosocomial lower respiratory tract infection in influenza-related acute respiratory distress syndrome. Chen WC; Kao KC; Sheu CC; Chan MC; Chen YM; Chien YC; Peng CK; Liang SJ; Hu HC; Tsai MJ; Fang WF; Perng WC; Wang HC; Wu CL; Yang KY; Ther Adv Respir Dis; 2020; 14():1753466620942417. PubMed ID: 32718277 [TBL] [Abstract][Full Text] [Related]
4. Metabolic Syndrome and Acute Respiratory Distress Syndrome in Hospitalized Patients With COVID-19. Denson JL; Gillet AS; Zu Y; Brown M; Pham T; Yoshida Y; Mauvais-Jarvis F; Douglas IS; Moore M; Tea K; Wetherbie A; Stevens R; Lefante J; Shaffer JG; Armaignac DL; Belden KA; Kaufman M; Heavner SF; Danesh VC; Cheruku SR; St Hill CA; Boman K; Deo N; Bansal V; Kumar VK; Walkey AJ; Kashyap R; JAMA Netw Open; 2021 Dec; 4(12):e2140568. PubMed ID: 34935924 [TBL] [Abstract][Full Text] [Related]
6. Acquired agitation in acute respiratory distress syndrome with COVID-19 compared to influenza patients: a propensity score matching observational study. Maamar A; Liard C; Doucet W; Reizine F; Painvin B; Delamaire F; Coirier V; Quelven Q; Guillot P; Lesouhaitier M; Tadié JM; Gacouin A Virol J; 2022 Sep; 19(1):145. PubMed ID: 36085163 [TBL] [Abstract][Full Text] [Related]
7. Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial. Maláska J; Stašek J; Duška F; Balík M; Máca J; Hruda J; Vymazal T; Klementová O; Zatloukal J; Gabrhelík T; Novotný P; Demlová R; Kubátová J; Vinklerová J; Svobodník A; Kratochvíl M; Klučka J; Gál R; Singer M; Trials; 2021 Mar; 22(1):172. PubMed ID: 33648568 [TBL] [Abstract][Full Text] [Related]
8. Predictors and Outcomes of Extracorporeal Membrane Oxygenation in COVID-19 Patients With ARDS: A Propensity-Matched Analysis of National Inpatient Sample. Ali S; Sattar Y; Erdem S; Hussain B; Duhan S; Atti L; Patel N; Hamza M; Gonuguntla K; Jalil B; Havistin R; Alamzaib SM; Elgendy IY; Daggubati R; Alraiyes AH; Alraies MC Curr Probl Cardiol; 2023 Nov; 48(11):101988. PubMed ID: 37473942 [TBL] [Abstract][Full Text] [Related]
9. Comparison of Clinical Features and Outcomes in Critically Ill Patients Hospitalized with COVID-19 versus Influenza. Cobb NL; Sathe NA; Duan KI; Seitz KP; Thau MR; Sung CC; Morrell ED; Mikacenic C; Kim HN; Liles WC; Luks AM; Town J; Pipavath S; Wurfel MM; Hough CL; West TE; Bhatraju PK Ann Am Thorac Soc; 2021 Apr; 18(4):632-640. PubMed ID: 33183067 [No Abstract] [Full Text] [Related]
10. Outcomes of Extracorporeal Membrane Oxygenation in Patients With Severe Acute Respiratory Distress Syndrome Caused by COVID-19 Versus Influenza. Shih E; Squiers JJ; DiMaio JM; George T; Banwait J; Monday K; Blough B; Meyer D; Schwartz GS Ann Thorac Surg; 2022 May; 113(5):1445-1451. PubMed ID: 34139189 [TBL] [Abstract][Full Text] [Related]
11. Effect of early treatment with polyvalent immunoglobulin on acute respiratory distress syndrome associated with SARS-CoV-2 infections (ICAR trial): study protocol for a randomized controlled trial. Mazeraud A; Gonçalves B; Aegerter P; Mancusi L; Rieu C; Bozza F; Sylla K; Siami S; Sharshar T Trials; 2021 Feb; 22(1):170. PubMed ID: 33648563 [TBL] [Abstract][Full Text] [Related]
12. Mortality in patients with COVID-19 versus non-COVID-19- related acute respiratory distress syndrome: A single center retrospective observational cohort study. Hsieh YH; Chang HT; Wang PH; Chang MY; Hsu HS PLoS One; 2023; 18(6):e0286564. PubMed ID: 37267339 [TBL] [Abstract][Full Text] [Related]
13. Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome. ; Davies A; Jones D; Bailey M; Beca J; Bellomo R; Blackwell N; Forrest P; Gattas D; Granger E; Herkes R; Jackson A; McGuinness S; Nair P; Pellegrino V; Pettilä V; Plunkett B; Pye R; Torzillo P; Webb S; Wilson M; Ziegenfuss M JAMA; 2009 Nov; 302(17):1888-95. PubMed ID: 19822628 [TBL] [Abstract][Full Text] [Related]
14. Outcomes of patients with COVID-19 acute respiratory distress syndrome requiring invasive mechanical ventilation admitted to an intensive care unit in South Africa. Arnold-Day C; Van Zyl-Smit RN; Joubert IA; Thomson DA; Fredericks DL; Miller MGA; Michell WL; Semple PL; Piercy JL S Afr Med J; 2022 Feb; 112(1):13516. PubMed ID: 35140002 [TBL] [Abstract][Full Text] [Related]
15. Extracorporeal Membrane Oxygenation with Right Ventricular Assist Device for COVID-19 ARDS. Cain MT; Smith NJ; Barash M; Simpson P; Durham LA; Makker H; Roberts C; Falcucci O; Wang D; Walker R; Ahmed G; Brown SA; Nanchal RS; Joyce DL J Surg Res; 2021 Aug; 264():81-89. PubMed ID: 33789179 [TBL] [Abstract][Full Text] [Related]
16. Dead space estimates may not be independently associated with 28-day mortality in COVID-19 ARDS. Morales-Quinteros L; Neto AS; Artigas A; Blanch L; Botta M; Kaufman DA; Schultz MJ; Tsonas AM; Paulus F; Bos LD; Crit Care; 2021 May; 25(1):171. PubMed ID: 34001222 [TBL] [Abstract][Full Text] [Related]
17. Comparative outcomes between COVID-19 and influenza patients placed on veno-venous extracorporeal membrane oxygenation for severe ARDS. Raff LA; Reid TD; Johnson D; Raff EJ; Schneider AB; Charles AG; Gallaher JR Am J Surg; 2022 Feb; 223(2):388-394. PubMed ID: 33894980 [TBL] [Abstract][Full Text] [Related]
18. Extracorporeal membrane oxygenation for pandemic influenza A(H1N1)-induced acute respiratory distress syndrome: a cohort study and propensity-matched analysis. Pham T; Combes A; Rozé H; Chevret S; Mercat A; Roch A; Mourvillier B; Ara-Somohano C; Bastien O; Zogheib E; Clavel M; Constan A; Marie Richard JC; Brun-Buisson C; Brochard L; Am J Respir Crit Care Med; 2013 Feb; 187(3):276-85. PubMed ID: 23155145 [TBL] [Abstract][Full Text] [Related]
19. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial. Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777 [TBL] [Abstract][Full Text] [Related]
20. Improved outcomes over time for adult COVID-19 patients with acute respiratory distress syndrome or acute respiratory failure. Yeates EO; Nahmias J; Chinn J; Sullivan B; Stopenski S; Amin AN; Nguyen NT PLoS One; 2021; 16(6):e0253767. PubMed ID: 34170950 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]